Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice

This publication has 40 references indexed in Scilit:

• Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion
  Journal of Clinical Investigation, 2010
• Direct CD1d-Mediated Stimulation of APC IL-12 Production and Protective Immune Response to Virus Infection In Vivo
  The Journal of Immunology, 2009
• Preactivation of NKT cells with α-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A_2Areceptor
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
• Distinct contributions of CD4⁺T cell subsets in hepatic ischemia/reperfusion injury
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
• Invariant Natural Killer T Cells Suppress the Neutrophil Inflammatory Response in a Mouse Model of Cholestatic Liver Damage
  Gastroenterology, 2009
• Cross‐regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens
  Journal of Cellular Physiology, 2008
• Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver disease
  Journal of Clinical Investigation, 2007
• Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
  Journal of Experimental Medicine, 2006
• Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
• Natural killer T cells as targets for immunotherapy of autoimmune diseases
  Immunology & Cell Biology, 2004